子宫内膜异位症和子宫腺肌症中子宫收缩力的功能决定因素:系统综述与荟萃分析
该系统综述与荟萃分析检索截至2024年5月2日的数据库,纳入9项观察性研究,比较子宫内膜异位症/子宫腺肌症女性与对照的子宫收缩力。子宫内膜异位症女性经期逆行子宫收缩风险升高(RR 8.63,95%CI 3.24-22.95,I²=0),经期和黄体期收缩频率平均差分别为0.82和0.52。作者认为异常子宫收缩力可能是子宫内膜异位症发病的机械因素,但证据确定性多为低。
要点
- 子宫内膜异位症女性经期逆行子宫收缩风险约为对照的8.63倍(95%CI 3.24-22.95,I²=0)。
- 收缩频率平均差经期0.82(95%CI 0.13-1.52,I²=18.61%),黄体期0.52(95%CI 0.22-0.83,I²=27.18%)。
- 因子宫腺肌症数据缺乏,多数比较的证据确定性评为低。
核心结论
- 子宫内膜异位症女性经期逆行子宫收缩模式风险约升高九倍,支持逆行月经在其发病机制中的潜在作用。
- 异常子宫收缩力可能不限于月经期,可能是促进子宫内膜异位症及相关症状(包括月经痛和不孕)发展的机械因素,子宫腺肌症证据有限但多一致。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed/MEDLINE、Embase和Scopus截至2024年5月2日。
- 纳入9项观察性研究,多数评估子宫内膜异位症女性,使用磁共振成像、超声、电生理或直接宫内压记录比较不同月经周期阶段的子宫收缩力定量指标。
- 研究质量采用纽卡斯尔-渥太华量表评估,合并估计采用随机效应模型。
- 注册号PROSPERO ID CRD42024512273,于2024年2月23日接受。
主要发现
- 子宫内膜异位症女性经期逆行子宫收缩风险较对照升高(风险比8.63,95%CI 3.24-22.95,I²=0)。
- 收缩频率平均差经期0.82(95%CI 0.13-1.52,I²=18.61%),黄体期0.52(95%CI 0.22-0.83,I²=27.18%)。
- 卵泡期和围排卵期结果异质性更大。
- 子宫内膜异位症或子宫腺肌症女性在所有月经周期阶段报告更高的收缩幅度。
关键数值与推荐
- 主要结局为病例与对照的逆行月经子宫收缩模式合并风险比。
- 次要结局为所有月经周期阶段子宫收缩力连续测量(频率、幅度和速度)的合并平均差。
临床怎么用
- 原文未据此给出推荐。
局限性
- 因子宫腺肌症数据缺乏,多数比较的证据确定性评为低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Evidence suggests that aberrant uterine contractility in nonpregnant women with endometriosis and adenomyosis contributes to symptoms and potentially heralds their pathogenesis. However, uterine peristalsis remains understudied, inconsistently measured, and poorly understood. OBJECTIVE: To summarize evidence on uterine contractility across the menstrual cycle phases in women with endometriosis and adenomyosis. DATA SOURCES: PubMed/MEDLINE, Embase, and Scopus databases searched up to May 2, 2024. STUDY SELECTION AND SYNTHESIS: Observational studies compared quantitative measures of uterine contractility using magnetic resonance imaging, ultrasound, electrophysiology, or direct intrauterine pressure recording across different menstrual cycle phases between women with endometriosis/adenomyosis and controls on the basis of predefined problem/population, intervention, comparison, and outcome criteria. Study quality was assessed using the Newcastle-Ottawa Scale. Pooled estimates for primary (risk ratios with 95% confidence intervals [CIs]) and secondary (mean difference [MD] with 95% CIs) outcomes were calculated using random-effects models. MAIN OUTCOMES: Pooled risk of retrograde menstruation uterine contraction pattern in cases vs. controls; pooled MD in continuous measures of uterine contractility (frequency, amplitude, and velocity of contractions) across all the menstrual cycle phases in cases vs. controls. RESULTS: Nine studies met the inclusion criteria; most were studies that evaluated women with endometriosis. An increased risk of retrograde uterine contractions during menstruation was observed in women with endometriosis compared with that in controls (risk ratio, 8.63; 95% CI, 3.24-22.95; I2, 0). The pooled MDs in contraction frequency between cases and controls were 0.82 (95% CI, 0.13-1.52; I2, 18.61%) in the menstrual phase and 0.52 (95% CI, 0.22-0.83; I2, 27.18%) in the luteal phase. Results for the follicular and periovulatory phases were more heterogeneous. Higher contraction amplitudes in women with endometriosis or adenomyosis were reported across all menstrual cycle phases. Because of the paucity of data, especially for adenomyosis, evidence certainty was graded as low for most comparisons. CONCLUSION AND RELEVANCE: The approximately ninefold increased risk of retrograde pattern during menstruation in endometriosis supports the potential role of retrograde menstruation in its etiopathogenesis. Abnormal uterine contractility, likely not limited to the menstrual phase, may be a mechanical factor contributing to development of endometriosis and related symptoms, including menstrual pain and infertility, with limited, mostly concordant evidence for adenomyosis. REGISTRATION NUMBER: PROSPERO ID CRD42024512273-accepted on February 23, 2024.
引用
- Salmeri N, Di Stefano G, Viganò P, et al. Functional determinants of uterine contractility in endometriosis and adenomyosis: a systematic review and meta-analysis. Fertil Steril. 2024. PMID: 39067674. doi:10.1016/j.fertnstert.2024.07.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。